These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glyceraldehyde 3-phosphate dehydrogenase augments the intercellular transmission and toxicity of polyglutamine aggregates in a cell model of Huntington disease. Mikhaylova ER; Lazarev VF; Nikotina AD; Margulis BA; Guzhova IV J Neurochem; 2016 Mar; 136(5):1052-63. PubMed ID: 26662373 [TBL] [Abstract][Full Text] [Related]
3. Differential ERK activation during autophagy induced by europium hydroxide nanorods and trehalose: Maximum clearance of huntingtin aggregates through combined treatment. Wei PF; Jin PP; Barui AK; Hu Y; Zhang L; Zhang JQ; Shi SS; Zhang HR; Lin J; Zhou W; Zhang YJ; Ruan RQ; Patra CR; Wen LP Biomaterials; 2015 Dec; 73():160-74. PubMed ID: 26409001 [TBL] [Abstract][Full Text] [Related]
4. Midazolam Enhances Mutant Huntingtin Protein Accumulation via Impairment of Autophagic Degradation In Vitro. Zhang J; Dai W; Geng P; Zhang L; Tan Q; Cheng D; Wei P; Yang Z; Zhang L; Gu E; Xu G; Liang C; Liu X Cell Physiol Biochem; 2018; 48(2):683-691. PubMed ID: 30025395 [TBL] [Abstract][Full Text] [Related]
5. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. Lee MN; Ha SH; Kim J; Koh A; Lee CS; Kim JH; Jeon H; Kim DH; Suh PG; Ryu SH Mol Cell Biol; 2009 Jul; 29(14):3991-4001. PubMed ID: 19451232 [TBL] [Abstract][Full Text] [Related]
6. Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes. Zhao T; Hong Y; Li S; Li XJ J Neurosci; 2016 Aug; 36(32):8317-28. PubMed ID: 27511006 [TBL] [Abstract][Full Text] [Related]
7. HIPK3 modulates autophagy and HTT protein levels in neuronal and mouse models of Huntington disease. Fu Y; Sun X; Lu B Autophagy; 2018; 14(1):169-170. PubMed ID: 29130397 [TBL] [Abstract][Full Text] [Related]
8. Assessing Autophagic Activity and Aggregate Formation of Mutant Huntingtin in Mammalian Cells. Stamatakou E; Zhu Y; Rubinsztein DC Methods Mol Biol; 2018; 1780():17-29. PubMed ID: 29856012 [TBL] [Abstract][Full Text] [Related]
9. The role of chaperone-mediated autophagy in huntingtin degradation. Qi L; Zhang XD; Wu JC; Lin F; Wang J; DiFiglia M; Qin ZH PLoS One; 2012; 7(10):e46834. PubMed ID: 23071649 [TBL] [Abstract][Full Text] [Related]
10. NAADP-Evoked Ca Pereira CAS; Medaglia NC; Ureshino RP; Bincoletto C; Antonioli M; Fimia GM; Piacentini M; Pereira GJDS; Erustes AG; Smaili SS Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982672 [TBL] [Abstract][Full Text] [Related]
11. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487 [TBL] [Abstract][Full Text] [Related]
12. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones. Luo H; Cao L; Liang X; Du A; Peng T; Li H Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620 [TBL] [Abstract][Full Text] [Related]
13. Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HD. Singer E; Walter C; Fabbro D; Rageot D; Beaufils F; Wymann MP; Rischert N; Riess O; Hillmann P; Nguyen HP Neuropharmacology; 2020 Jan; 162():107812. PubMed ID: 31622602 [TBL] [Abstract][Full Text] [Related]
14. The Cytotoxicity and Clearance of Mutant Huntingtin and Other Misfolded Proteins. Folger A; Wang Y Cells; 2021 Oct; 10(11):. PubMed ID: 34831058 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models. Coudert L; Nonaka T; Bernard E; Hasegawa M; Schaeffer L; Leblanc P Cell Mol Life Sci; 2019 Jul; 76(13):2615-2632. PubMed ID: 30863908 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease. Rippin I; Bonder K; Joseph S; Sarsor A; Vaks L; Eldar-Finkelman H Neurobiol Dis; 2021 Jul; 154():105336. PubMed ID: 33753290 [TBL] [Abstract][Full Text] [Related]
18. Role of chaperone-mediated autophagy in degrading Huntington's disease-associated huntingtin protein. Qi L; Zhang XD Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):83-91. PubMed ID: 24323530 [TBL] [Abstract][Full Text] [Related]
19. Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease. Yang W; Xie J; Qiang Q; Li L; Lin X; Ren Y; Ren W; Liu Q; Zhou G; Wei W; Saiyin H; Ma L Neurosci Bull; 2019 Dec; 35(6):1024-1034. PubMed ID: 31432317 [TBL] [Abstract][Full Text] [Related]